ADVFN Logo ADVFN
시장 데이터
뉴스
도구
시장
팔로우

Hot Features

피드 팔로우

Follow Feed 커뮤니티에서 거래자 및 투자자와 연결하세요.

실시간 옵션 플로우

포괄적인 옵션 데이터를 탐색하고 옵션 흐름으로 고급 필터를 사용하세요.

모니터

터미널 모니터로 주식 및 자산 관심 목록을 구성하고 모니터링하세요.
로그인 Premium Icon프리미엄 Help Menu
S&P 500
5,116.17
0.00%
US Tech 100
17,292.00
-0.10%
다우존스 지수
38,386.09
0.00%
Bitcoin
61,209.77
-4.12%
Registration Strip Icon for default 무료로 등록하여 실시간 주식 시세, 대화형 차트, 실시간 옵션 플로우 등을 받아보세요.
등록
  1. 홈
  2. 인베스팅
  3. 주식
  4. 미국
  5. NASDAQ
  6. Rocket Pharmaceuticals Inc (RCKT)

  7. Rocket Pharmaceuticals Inc (RCKT) 뉴스

RCKT Rocket Pharmaceuticals Inc

21.85
0.00 (0.00%)
시간외 단일가
최종 업데이트: 21:14:11
15분 지연
기업명 주식 심볼 시장 주식 타입
Rocket Pharmaceuticals Inc RCKT 나스닥 보통주
  가격 변동 가격 변동 % 주식 가격 최근 거래 시간
Upgrade Icon
0.00 0.00% 21.85 21:14:11
개장가 저가 고가 종가 전일 종가
21.85
시세 정보 더보기 »

최근 뉴스

일자 시간 출처 제목
02/04/202419:00BWRocket Pharmaceuticals Announces European Medicines Agency..
27/03/202405:01BWRocket Pharmaceuticals Announces Appointment of Aaron Ondrey..
05/03/202408:54EDGAR2Form 4 - Statement of changes in beneficial ownership of..
05/03/202408:48EDGAR2Form 4 - Statement of changes in beneficial ownership of..
01/03/202405:54EDGAR2Form 144 - Report of proposed sale of securities
01/03/202404:59EDGAR2Form 144 - Report of proposed sale of securities
27/02/202406:37EDGAR2Form 8-K - Current report
27/02/202406:01BWRocket Pharmaceuticals Reports Fourth Quarter and Full Year..
22/02/202410:54EDGAR2Form 4 - Statement of changes in beneficial ownership of..
22/02/202410:54EDGAR2Form 4 - Statement of changes in beneficial ownership of..
22/02/202410:54EDGAR2Form 4 - Statement of changes in beneficial ownership of..
22/02/202410:54EDGAR2Form 4 - Statement of changes in beneficial ownership of..
22/02/202410:54EDGAR2Form 4 - Statement of changes in beneficial ownership of..
17/02/202407:28EDGAR2Form 144/A - Report of proposed sale of securities: [Amend]
17/02/202406:37EDGAR2Form 144 - Report of proposed sale of securities
17/02/202406:31EDGAR2Form 144 - Report of proposed sale of securities
17/02/202406:26EDGAR2Form 144 - Report of proposed sale of securities
17/02/202406:22EDGAR2Form 144 - Report of proposed sale of securities
17/02/202406:05EDGAR2Form 4 - Statement of changes in beneficial ownership of..
17/02/202406:05EDGAR2Form 4 - Statement of changes in beneficial ownership of..
17/02/202406:05EDGAR2Form 4 - Statement of changes in beneficial ownership of..
14/02/202406:37EDGAR2Form 8-K - Current report
13/02/202421:00BWRocket Pharmaceuticals Announces Update on FDA Review..
30/01/202405:26EDGAR2Form SC 13G/A - Statement of acquisition of beneficial..
24/01/202406:22EDGAR2Form 4 - Statement of changes in beneficial ownership of..
23/01/202406:05EDGAR2Form 4 - Statement of changes in beneficial ownership of..
23/01/202405:16EDGAR2Form 144 - Report of proposed sale of securities
03/01/202406:01BWRocket Pharmaceuticals to Present at 42nd Annual J.P. Morgan..
14/12/202306:05EDGAR2Form 8-K - Current report
13/12/202310:51EDGAR2Form 4 - Statement of changes in beneficial ownership of..
13/12/202310:42EDGAR2Form 3 - Initial statement of beneficial ownership of..
12/12/202321:00BWRocket Pharmaceuticals Appoints R. Keith Woods to Board of..
17/11/202309:24EDGAR2Form 4 - Statement of changes in beneficial ownership of..
17/11/202309:17EDGAR2Form 4 - Statement of changes in beneficial ownership of..
17/11/202309:09EDGAR2Form 4 - Statement of changes in beneficial ownership of..
17/11/202308:58EDGAR2Form 4 - Statement of changes in beneficial ownership of..
17/11/202305:28EDGAR2Form 144 - Report of proposed sale of securities
17/11/202305:21EDGAR2Form 144 - Report of proposed sale of securities
17/11/202305:21EDGAR2Form 144 - Report of proposed sale of securities
08/11/202306:40EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
07/11/202306:04BWRocket Pharmaceuticals Reports Third Quarter 2023 Financial..
25/10/202322:38EDGAR2Form 4 - Statement of changes in beneficial ownership of..
21/10/202304:19EDGAR2Form 144 - Report of proposed sale of securities
19/10/202320:00BWRocket Pharmaceuticals Announces Presentations Highlighting..
11/10/202305:11EDGAR2Form 4 - Statement of changes in beneficial ownership of..
03/10/202310:02EDGAR2Form 4 - Statement of changes in beneficial ownership of..
03/10/202305:05EDGAR2Form 8-K - Current report
02/10/202320:00BWRocket Pharmaceuticals Announces FDA Acceptance of Biologics..
27/09/202305:01BWRocket Pharmaceuticals to Participate in the Chardan 7th..
21/09/202305:09EDGAR2Form 424B5 - Prospectus [Rule 424(b)(5)]

최근 히스토리

NASDAQ
RCKT
Rocket Pharmaceuticals
Delayed Upgrade Clock
ADVFN Logo

대한변국
회사 소개
사업
Popular
앱 받기

도움 및 지원받기: kr-support@advfn.com

ADVFN 서비스 이용은 ADVFN의 이용약관에 동의하는 것입니다 이용약관

© 2024 ADVFN PLC - 모든 권리 보유